Neurocrine Biosciences Surges On Takeover Speculation

Shares of Neurocrine Biosciences Inc. (NASDAQ: NBIX) surged more than 6% on Wednesday on speculation that the company could be acquired by Eli Lilly & Co. (NYSE: LLY). Stay tuned for more.

Full Disclosure: None.